Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.
D000083:Acetanilides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000526:Alprenolol / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004558:Electric Stimulation; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006614:Hindlimb; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D000526:Alprenolol; D012110:Reserpine; D011433:Propranolol; D007545:Isoproterenol